Back to BlackRock, Inc. BlackRock, Inc.

IKTIKT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in INHIBIKASE THERAPEUTICS INC

BlackRock, Inc. holds 7.8M shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $15.8M as of 2026-Q2. The position was increased (+23.2% shares). IKT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$15.8M

Current Shares

7.8M

Total Value Change

+$14.7M

Total Shares Change

+7.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.8M
+23.2%
$15.8M0.0%$2.03
34
2026-Q1
Increased
6.3M
+90.7%
$10.6M0.0%$1.91
44
2025-Q4
Increased
3.3M
+7.5%
$6.8M0.0%$1.97
29
2025-Q3
Increased
3.1M
+12.7%
$5M0.0%$1.53
30
2025-Q2
Increased
2.7M
+543.5%
$5.3M0.0%$1.62
44
2025-Q1
Increased
423,979
+26.4%
$928,5140.0%$2.29
21
2024-Q4
New
335,460
-
$1.1M0.0%$3.24
38

Other major holders of IKT: Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used